Evidence map›Paper›PMID 40936950›Full record

ArticleRSC advances2025

Skin-derived volatile organic compounds trigger redox signalling pathways in human keratinocytes

M Finnegan, V Bolikava, N Walsh, A Morrin

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M FinneganSchool of Chemical Sciences, Insight Research Ireland Centre for Data Analytics, The RAPID Institute, Dublin City University D09 V209 Ireland aoife.morrin@dcu.ie.
V BolikavaSchool of Chemical Sciences, Insight Research Ireland Centre for Data Analytics, The RAPID Institute, Dublin City University D09 V209 Ireland aoife.morrin@dcu.ie.
N WalshSchool of Biotechnology, Life Sciences Institute, Dublin City University D09 V209 Ireland.
A MorrinSchool of Chemical Sciences, Insight Research Ireland Centre for Data Analytics, The RAPID Institute, Dublin City University D09 V209 Ireland aoife.morrin@dcu.ie.ORCID https://orcid.org/0000-0002-3031-4794

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human skin emits a diverse range of volatile organic compounds (VOCs) originating from both endogenous metabolic activity and microbial transformation of sweat and sebum. While these volatiles have been profiled extensively, their potential to influence host cellular processes remains largely unexplored. In this study, we investigate the capacity of five skin-relevant VOCs-nonanal, decanal, 6-methyl-5-hepten-2-one (6MHO), acetic acid (AA), and 2-ethyl-1-hexanol (2EH) - to induce redox signalling pathways in keratinocytes. We demonstrate that selected compounds, particularly nonanal, decanal and AA, induce intracellular reactive oxygen species (ROS) and activate the Nrf2-Keap1 antioxidant defence mechanism. Using both conventional liquid-phase treatment and a custom-designed headspace system for gas-phase treatment, we show that these VOCs elicit this signalling response from both liquid and gas phases. These findings provide the first mechanistic evidence that endogenous or microbially-derived VOCs from skin can function as gaseous redox modulators, capable of triggering protective cellular responses from a distance. This work presents new evidence for cell-cell volatile communication in skin and through its resident microbiota, offering insights into the signalling potential of volatile metabolites.

Identifiers

PMID40936950
PMCPMC12421873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.